发明名称 PHARMACEUTICAL FORMULATION BETWEEN JASMONATE AND DERIVATIVE THEREOF AND NANOCARRIER OR MICROCARRIER
摘要 PROBLEM TO BE SOLVED: To provide a pharmaceutical formulation and a cosmetic formulation capable of minimizing side effect such as organoleptic, in a jasmonate family compound used for treatment for caner, treatment for viral, bacterial or fungous disease, and cosmetic.SOLUTION: A pharmaceutical formulation and a cosmetic formulation comprise: an active ingredient selected from the group consisting of methyl jasmonate, jasmonate acid, cucurbic acid, 6-epi-cucurbic acid, 6-epi-cucurbic acid lactone, 12-hydroxyjasmonic acid, 12-hydroxyjasmonic acid lactone, tuberonic acid, tuberonic-O-&bgr;-glucopyranosidic acid and cucurbic-O-&bgr;-glucopyranosidic acid; and a nanocarrier or a microcarrier. The active ingredient is encapsulated in the nanocarrier or the microcarrier, is present inside the nanocarrier or the microcarrier, is bound to the nanocarrier or the microcarrier, is complexed with the nanocarrier or the microcarrier, and/or is held on the nanocarrier or the microcarrier. The nanocarrier or the microcarrier is liposome or the like.
申请公布号 JP2014237688(A) 申请公布日期 2014.12.18
申请号 JP20140157671 申请日期 2014.08.01
申请人 JOSE E FEHR PEREIRA LOPES 发明人 JOSE E FEHR PEREIRA LOPES
分类号 A61K31/19;A61K8/02;A61K8/11;A61K8/14;A61K8/365;A61K8/37;A61K8/49;A61K8/60;A61K8/64;A61K8/73;A61K8/84;A61K8/97;A61K9/127;A61K9/50;A61K9/51;A61K31/215;A61K31/365;A61K31/7028;A61K47/34;A61K47/36;A61K47/42;A61K47/44;A61K47/46;A61K47/48;A61P17/00;A61P31/04;A61P31/10;A61P31/12;A61P35/00;A61Q19/00 主分类号 A61K31/19
代理机构 代理人
主权项
地址